INO.com Traders Blog http://ift.tt/2vxTIvc
Introduction CVS Health Corporation (NYSE:CVS) is fresh off reporting earnings for FYQ2 with beats on both the top and bottom line. EPS came in at $1.33 with revenue coming in at $45.69 billion, beating by $0.02 and $320 million, respectively. Since reporting earnings, the stock hasn’t moved as much of the pessimistic narrative was priced […]
The post CVS Posts Robust Earnings - Compelling Long-Term Buy appeared first on INO.com Traders Blog.
No comments:
Post a Comment